CORT FY 2019 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$306M+22.0% YoY

Gross Profit

$301M98.2% margin

Operating Income

$112M36.4% margin

Net Income

$94M30.7% margin

EPS (Diluted)

$0.77

Cash Flow

Operating Cash Flow

$136M

Free Cash Flow

$135M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$412M

Total Liabilities

$41M

Stockholders' Equity

$371M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$306M	$251M	+22.0%
Gross Profit	$301M	$246M	+22.3%
Operating Income	$112M	$89M	+24.7%
Net Income	$94M	$75M	+24.9%